Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a cash flow conversion efficiency ratio of 0.057x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL180.45 Million ≈ $4.04 Million USD) by net assets (TL3.17 Billion ≈ $71.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Meditera Tibbi Malzeme Sanayi ve Ticaret for the company's overall valuation and market capitalisation.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Meditera Tibbi Malzeme Sanayi ve Ticaret AS ranked by their cash flow conversion efficiency. Explore Meditera Tibbi Malzeme Sanayi ve Ticaret (MEDTR) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lohakit Metal Public Company Limited
BK:LHK
|
0.043x |
|
Surapon Foods Public Company Limited
BK:SSF
|
0.082x |
|
STG International Ltd
TA:STG
|
0.095x |
|
Panstar Enterprise Co.Ltd
KQ:054300
|
-0.018x |
|
Lake Victoria Gold Ltd.
V:LVG
|
-0.070x |
|
RIT Capital Partners
LSE:RCP
|
0.020x |
|
Hyundai HT CoLtd
KQ:039010
|
0.046x |
|
MODULIGHT OY EO 1
F:78W
|
0.001x |
Annual Cash Flow Conversion Efficiency for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)
The table below shows the annual cash flow conversion efficiency of Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2018 to 2025. View latest Meditera Tibbi Malzeme Sanayi ve Ticaret stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | TL2.93 Billion ≈ $65.61 Million |
TL435.35 Million ≈ $9.75 Million |
0.149x | -44.31% |
| 2024-12-31 | TL2.93 Billion ≈ $65.52 Million |
TL780.69 Million ≈ $17.49 Million |
0.267x | -28.82% |
| 2023-12-31 | TL2.14 Billion ≈ $47.85 Million |
TL801.02 Million ≈ $17.94 Million |
0.375x | +6421.15% |
| 2022-12-31 | TL887.08 Million ≈ $19.87 Million |
TL5.10 Million ≈ $114.23K |
0.006x | -91.07% |
| 2021-12-31 | TL569.37 Million ≈ $12.75 Million |
TL36.64 Million ≈ $820.70K |
0.064x | -80.92% |
| 2020-12-31 | TL217.15 Million ≈ $4.86 Million |
TL73.26 Million ≈ $1.64 Million |
0.337x | +113.28% |
| 2019-12-31 | TL126.49 Million ≈ $2.83 Million |
TL20.01 Million ≈ $448.12K |
0.158x | -76.66% |
| 2018-12-31 | TL108.11 Million ≈ $2.42 Million |
TL73.26 Million ≈ $1.64 Million |
0.678x | -- |
About Meditera Tibbi Malzeme Sanayi ve Ticaret AS
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi manufactures and sells medical devices in Turkey. The company offers two-way and single-line Infusion Systems; Chemotherapy Preparation and Administration Systems, such as medoconco automated drug preparation, diana semi-automatic drug dispensing, and ICU medical chemotherapy drug delivery systems; and respiratory systems products, includin… Read more